Detalles de la búsqueda
1.
Identification of fibroblast growth factor receptor 3 (FGFR3) as a protein receptor for botulinum neurotoxin serotype A (BoNT/A).
PLoS Pathog
; 9(5): e1003369, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23696738
2.
Location of the synaptosome-binding regions on botulinum neurotoxin B.
Biochemistry
; 51(1): 316-28, 2012 Jan 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-22146011
3.
Reengineering the specificity of the highly selective Clostridium botulinum protease via directed evolution.
Sci Rep
; 12(1): 9956, 2022 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-35705606
4.
Characterization of Förster resonance energy transfer in a botulinum neurotoxin protease assay.
Anal Biochem
; 413(1): 43-9, 2011 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21300021
5.
Depolarization after resonance energy transfer (DARET): a sensitive fluorescence-based assay for botulinum neurotoxin protease activity.
Anal Biochem
; 413(1): 36-42, 2011 Jun 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-21300022
6.
OnabotulinumtoxinA Displays Greater Biological Activity Compared to IncobotulinumtoxinA, Demonstrating Non-Interchangeability in Both In Vitro and In Vivo Assays.
Toxins (Basel)
; 12(6)2020 06 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32545832
7.
Molecular recognition of botulinum neurotoxin B heavy chain by human antibodies from cervical dystonia patients that develop immunoresistance to toxin treatment.
Mol Immunol
; 45(15): 3878-88, 2008 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-18676021
8.
Immune recognition of botulinum neurotoxin B: antibody-binding regions on the heavy chain of the toxin.
Mol Immunol
; 45(4): 910-24, 2008 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-17897717
9.
Molecular bases of protective immune responses against botulinum neurotoxin A--how antitoxin antibodies block its action.
Crit Rev Immunol
; 27(4): 319-41, 2007.
Artículo
en Inglés
| MEDLINE | ID: mdl-18197812
10.
Mapping of the regions on the heavy chain of botulinum neurotoxin A (BoNT/A) recognized by antibodies of cervical dystonia patients with immunoresistance to BoNT/A.
Mol Immunol
; 44(5): 1029-41, 2007 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-16647121
11.
Mapping of the synaptosome-binding regions on the heavy chain of botulinum neurotoxin A by synthetic overlapping peptides encompassing the entire chain.
Protein J
; 23(8): 539-52, 2004 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-15648976
12.
Synaptotagmin II and gangliosides bind independently with botulinum neurotoxin B but each restrains the other.
Protein J
; 33(3): 278-88, 2014 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24740609
13.
The binding sites on botulinum neurotoxin B for synaptotagmin and for blocking antibodies.
Biochem Biophys Res Commun
; 376(3): 631-2, 2008 Nov 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-18796292
14.
Molecular immune recognition of botulinum neurotoxin B. The light chain regions that bind human blocking antibodies from toxin-treated cervical dystonia patients. Antigenic structure of the entire BoNT/B molecule.
Immunobiology
; 217(1): 17-27, 2012 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-21962573
15.
Antibodies against a synthetic peptide designed to mimic a surface area of the H chain of botulinum neurotoxin A.
Immunol Lett
; 142(1-2): 20-7, 2012 Feb 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-22123395
16.
Regions of recognition by blocking antibodies on the light chain of botulinum neurotoxin A: antigenic structure of the entire toxin.
Immunobiology
; 216(6): 698-706, 2011 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-21183243
17.
Regions of botulinum neurotoxin A light chain recognized by human anti-toxin antibodies from cervical dystonia patients immunoresistant to toxin treatment. The antigenic structure of the active toxin recognized by human antibodies.
Immunobiology
; 216(7): 782-92, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21281977
18.
Inhibition of botulinum neurotoxin a toxic action in vivo by synthetic synaptosome- and blocking antibody-binding regions.
Protein J
; 29(5): 320-7, 2010 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-20571899
19.
Novel chimeras of botulinum neurotoxins A and E unveil contributions from the binding, translocation, and protease domains to their functional characteristics.
J Biol Chem
; 283(25): 16993-7002, 2008 Jun 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-18400760
20.
Is the light chain subcellular localization an important factor in botulinum toxin duration of action?
Mov Disord
; 19 Suppl 8: S23-34, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-15027051